Yahoo
BSE - Delayed Quote INR

Ajanta Pharma Limited (AJANTPHARM.BO)

3,317.75 -76.90 (-2.27%)
At close: 3:29:59 PM GMT+5:30
View in AlphaSpace Currency in INR All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
57,305,700
54,072,600
45,875,100
41,615,900
37,075,200
Cost of Revenue
12,996,700
12,477,000
11,271,500
11,153,200
11,167,300
Gross Profit
44,309,000
41,595,600
34,603,600
30,462,700
25,907,900
Operating Expense
29,143,800
28,329,600
23,319,000
20,006,300
19,110,300
Operating Income
15,165,200
13,266,000
11,284,600
10,456,400
6,797,600
Net Non Operating Interest Income Expense
375,700
354,900
264,300
205,000
26,200
Pretax Income
14,933,200
13,776,500
11,891,600
11,139,300
7,452,500
Tax Provision
3,584,400
3,216,500
2,687,700
2,977,600
1,572,700
Net Income Common Stockholders
11,348,800
10,560,000
9,203,900
8,161,700
5,879,800
Average Dilution Earnings
--
0
0
0
0
Diluted NI Available to Com Stockholders
11,348,800
10,560,000
9,203,900
8,161,700
5,879,800
Rent Expense Supplemental
--
88,500
93,300
73,800
75,900
Total Expenses
42,140,500
40,806,600
34,590,500
31,159,500
30,277,600
Net Income from Continuing & Discontinued Operation
11,348,800
10,560,000
9,203,900
8,161,700
5,879,800
Normalized Income
12,068,188.62
11,285,568.90
9,189,039.20
7,954,199.36
5,953,571.50
Interest Income
--
516,000
471,600
277,100
84,600
Interest Expense
140,300
161,100
207,300
72,100
58,400
Net Interest Income
375,700
354,900
264,300
205,000
26,200
EBIT
15,073,500
13,937,600
12,098,900
11,211,400
7,510,900
EBITDA
16,837,000
15,669,000
13,540,000
12,565,400
8,818,900
Reconciled Cost of Revenue
12,996,700
12,477,000
11,271,500
11,153,200
11,167,300
Reconciled Depreciation
1,763,500
1,731,400
1,441,100
1,354,000
1,308,000
Net Income from Continuing Operation Net Minority Interest
11,348,800
10,560,000
9,203,900
8,161,700
5,879,800
Total Unusual Items Excluding Goodwill
-946,600
-946,600
19,200
283,200
-93,500
Total Unusual Items
-946,600
-946,600
19,200
283,200
-93,500
Normalized EBITDA
17,783,600
16,615,600
13,520,800
12,282,200
8,912,400
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-227,211.38
-221,031.10
4,339.20
75,699.36
-19,728.50
3/31/2023 - 7/17/2026

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: